Aspira Women's Health Inc. 10-Q filing
Filed 2025-08-13 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0001493152-25-011865
- Form type
- 10-Q
- CIK
- 0000926617
- Primary document
- https://www.sec.gov/Archives/edgar/data/926617/000149315225011865/form10-q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Aspira Women's Health Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $4.7M | - | - |
| Cost Of Revenue | $1.6M | - | - |
| Gross Profit | $3.1M | - | - |
| Operating Income | $-5.0M | - | - |
| Net Income | $-4.5M | - | - |
| Eps Basic | -0.16 | - | - |
| Eps Diluted | -0.16 | - | - |
| Cash And Equivalents | $1.5M | - | - |
| Total Assets | $4.9M | - | - |
| Total Liabilities | $7.6M | - | - |
| Shareholders Equity | $-2.7M | - | - |
| Operating Cash Flow | $-4.8M | - | - |
| Capital Expenditures | $35,000 | - | - |